Although there is a strong pathophysiologic basis to support a role for MPO in human atherosclerosis [1], [2], Brennan et al provided evidence of increased lesion formation in LDL receptor-MPO double knockout mice compared to LDL−/−mice [28]. This evidence concerns the gene LDLR and atherosclerosis.